GlassScriptPhysician profile
Brian G Sperl
NPI 1720085871
$3,264.62
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $1,048 · 2021: $1,416.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $946.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $790.46 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $457.95 | 2019-2021 | |
| Gilead Sciences, INC. | $283.41 | 2019-2021 | |
| Redhill Biopharma INC. | $221.98 | 2020-2021 | |
| Ucb, INC. | $139.49 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $76.35 | 2021 | |
| Braintree Laboratories, INC. | $47.10 | 2021 | |
| Intercept Pharmaceuticals, INC. | $45.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $44.94 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $35.57 | 2020-2021 | |
| Janssen Biotech, INC. | $24.68 | 2020-2021 | |
| Concordia Pharmaceuticals INC. | $23.52 | 2019 | |
| Romark Laboratories, Lc | $19.95 | 2020 | |
| Alnylam Pharmaceuticals INC. | $19.49 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $17.83 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.44 | 2019 | |
| Alfasigma USA, INC. | $14.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.66 | 2019 | |
| Pfizer INC. | $13.63 | 2019 | |
| Allergan, INC. | $11.35 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sperl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.